Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
We can see a decrease in the price for Clinuvel Pharmaceuticals. Compared to yesterday it has lost -€0.070 (-1.270%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -1.270% | 0.290% | -11.332% | -7.548% | -21.812% | -55.984% | -71.063% |
| Carbylan Therapeutics Inc | -1.570% | -5.549% | 11.156% | 57.115% | 28.661% | 128.531% | -23.645% |
| Pharma Mar S.A. | 0.220% | 7.073% | 18.523% | 24.216% | 23.721% | 120.407% | -0.789% |
| Mayne Pharma Group Ltd. | 9.400% | 3.226% | -2.290% | -66.667% | -20.988% | -48.387% | 374.074% |
